Trusted Resources: Education
Scientific literature and patient education texts
Ethical Perspectives on Treatment Options With Spinal Muscular Atrophy Patients
source: Annals of neurology
year: 2022
authors: Yeo CJJ,Simmons Z,De Vivo DC,Darras BT
summary/abstract:Since 2016, three innovative therapies for spinal muscular atrophy have changed the face of disease. Although these therapies often result in remarkable improvements in infants and children, benefits in adults are modest and treatment is not curative. Concerns have been raised about the enormous costs of these medications, the ultimate burden to taxpayers, and the costs to society of withholding treatments and sacrificing or disadvantaging some individuals. Physicians are best positioned to serve our patients by carefully considering the costs, benefits, implications for quality of life, and the interplay of these factors within the framework of core ethical principles that guide clinical care. This article is protected by copyright. All rights reserved.
organization: Boston Children's Hospital, Harvard Medical School, Boston, MA, USA.DOI: 10.1002/ana.26299
read more
Related Content
-
Gene Replacement Therapy With Onasemnogene Abeparvovec in Children With Spinal Muscular Atrophy Aged 24 Months or Yo...Given the novelty of gene replacement th...
-
Risdiplam for the Use of Spinal Muscular AtrophySpinal muscular atrophy (SMA) is one of ...
-
Lunch & Learn: Gene Therapy for SMAhttps://www.youtube.com/watch?v=YFEMR1ZH...
-
FDA-Approved Treatment Provides Life-Saving Miracle for Girl With Spinal Muscular AtrophyAlex says her daughter made it to Norton...
-
Nusinersen for Spinal Muscular Atrophy in the United States: Findings From a Retrospective Claims Database AnalysisSpinal muscular atrophy (SMA) is a rare,...
-
Improvement in Fine Manual Dexterity in Children With Spinal Muscular Atrophy Type 2 After Nusinersen Injection: A C...Although nusinersen has been demonstrate...
-
The Antisense Oligonucleotide Nusinersen for Treatment of Spinal Muscular AtrophySpinal muscular atrophy (SMA) is a rare,...